Therefore, measuring the expression of MMP-9 and its endogenous inhibitor, monitoring the dynamic changes of BBB structure after stroke and finding pathways to target the main proteins involved may lead to more effective protection of the BBB and improved therapeutic approaches for stroke. This evidence concerns the gene MMP9 and Stroke.